Last 12 months
Inside the activity.
1 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 3, 2022 20:17 UTC |
JACKSON REX SChief Financial Officer
|
GrantCommon Stock | 358,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021110 · doc4.xml · nonDerivative · entry 2 JACKSON REX S · CIK 0001249803 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,135,057 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:17 UTC |
JACKSON REX SChief Financial Officer
|
GrantCommon Stock | 331,272 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021110 · doc4.xml · nonDerivative · entry 1 JACKSON REX S · CIK 0001249803 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,891 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:16 UTC |
Hughes Michael DSee Remarks
|
GrantCommon Stock | 358,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021108 · doc4.xml · nonDerivative · entry 2 Hughes Michael D · CIK 0001590392 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972,855 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:16 UTC |
Hughes Michael DSee Remarks
|
GrantCommon Stock | 331,272 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021108 · doc4.xml · nonDerivative · entry 1 Hughes Michael D · CIK 0001590392 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,689 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:21 UTC |
Jansen ColleenChief Marketing Officer
|
GrantCommon Stock | 119,388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021119 · doc4.xml · nonDerivative · entry 2 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,825 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:21 UTC |
Jansen ColleenChief Marketing Officer
|
GrantCommon Stock | 110,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021119 · doc4.xml · nonDerivative · entry 1 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,437 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:20 UTC |
Chavez RebeccaGeneral Counsel and Secretary
|
GrantCommon Stock | 95,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021117 · doc4.xml · nonDerivative · entry 2 Chavez Rebecca · CIK 0001847025 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,786 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:20 UTC |
Chavez RebeccaGeneral Counsel and Secretary
|
GrantCommon Stock | 88,339 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021117 · doc4.xml · nonDerivative · entry 1 Chavez Rebecca · CIK 0001847025 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,276 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:19 UTC |
Romano PasqualeDirector · President and CEO
|
GrantCommon Stock | 716,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021116 · doc4.xml · nonDerivative · entry 2 Romano Pasquale · CIK 0001838832 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,145,304 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 3-year period commencing on June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 3-year period commencing on June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:19 UTC |
Romano PasqualeDirector · President and CEO
|
GrantCommon Stock | 662,544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021116 · doc4.xml · nonDerivative · entry 1 Romano Pasquale · CIK 0001838832 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,428,972 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period after June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period after June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:19 UTC |
Sidle EricChief Technology Officer
|
GrantCommon Stock | 143,266 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021115 · doc4.xml · nonDerivative · entry 2 Sidle Eric · CIK 0001837954 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,271 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:19 UTC |
Sidle EricChief Technology Officer
|
GrantCommon Stock | 132,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021115 · doc4.xml · nonDerivative · entry 1 Sidle Eric · CIK 0001837954 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,005 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:18 UTC |
Loewenthal William JChief Product Officer
|
GrantCommon Stock | 119,388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021114 · doc4.xml · nonDerivative · entry 2 Loewenthal William J · CIK 0001837881 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,538 F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:18 UTC |
Loewenthal William JChief Product Officer
|
GrantCommon Stock | 110,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-021114 · doc4.xml · nonDerivative · entry 1 Loewenthal William J · CIK 0001837881 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,150 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20. Read SEC document |
| May 22, 2022 Filed May 16, 2022 21:00 UTC |
Loewenthal William JSenior Vice President, Product
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $0.56 | Not disclosed |
DisclosureSEC source: 0000899243-22-018162 · doc4.xml · derivative · entry 2 Loewenthal William J · CIK 0001837881 · Senior Vice President, Product 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,934 Underlying: Common Stock · 25,000 shares Expires 2028-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. F1 · derivative.exercise_date: The Stock Option vests in 48 equal monthly installments from July 30, 2018, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:00 UTC |
JACKSON REX SChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,196 | Not disclosed Strike: $0.56 | Not disclosed |
DisclosureSEC source: 0000899243-22-018860 · doc4.xml · derivative · entry 3 JACKSON REX S · CIK 0001249803 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476,060 Underlying: Common Stock · 50,196 shares Expires 2028-07-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. F2 · derivative.exercise_date: The Stock Option vests in 48 equal monthly installments from May 29, 2018, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:00 UTC |
JACKSON REX SChief Financial Officer
|
Exercise / conversionCommon Stock | 50,196 | $0.56 | $28,109.76 |
DisclosureSEC source: 0000899243-22-018860 · doc4.xml · nonDerivative · entry 1 JACKSON REX S · CIK 0001249803 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2022 Filed May 16, 2022 21:00 UTC |
Loewenthal William JSenior Vice President, Product
|
Exercise / conversionCommon Stock | 25,000 | $0.56 | $14,000.00 |
DisclosureSEC source: 0000899243-22-018162 · doc4.xml · nonDerivative · entry 1 Loewenthal William J · CIK 0001837881 · Senior Vice President, Product 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 21:00 UTC |
Romano PasqualeDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 250,000 | Not disclosed Strike: $0.27 | Not disclosed |
DisclosureSEC source: 0000899243-22-015660 · doc4.xml · derivative · entry 3 Romano Pasquale · CIK 0001838832 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,802 Underlying: Common Stock · 250,000 shares Expires 2022-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 21:00 UTC |
Romano PasqualeDirector · President and CEO
|
SaleCommon Stock | 250,000 | $14.62 | $3,655,125.00 |
DisclosureSEC source: 0000899243-22-015660 · doc4.xml · nonDerivative · entry 2 Romano Pasquale · CIK 0001838832 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,766,428 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $14.32 to $15.15. The Reporting Person has provided to the issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 21:00 UTC |
Romano PasqualeDirector · President and CEO
|
Exercise / conversionCommon Stock | 250,000 | $0.27 | $67,500.00 |
DisclosureSEC source: 0000899243-22-015660 · doc4.xml · nonDerivative · entry 1 Romano Pasquale · CIK 0001838832 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Reporting Person exercised these options, which otherwise will expire on June 10, 2022, for shares of common stock to be sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 9,841 | $16.14 | $158,833.74 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 6 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F6 · ownership.nature: Consists of securities held directly by Levitate Capital GP LP ("Levitate GP"). Linse Capital Management PR LLC ("LCMPR") is the general partner of Levitate GP. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Levitate GP. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 29,333 | $16.17 | $474,314.61 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 5 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,794,993 F5 · ownership.nature: Consists of securities held directly by Linse Capital CP V, LLC ("Linse V"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse V. Mr. Linse has sole voting and investment power over the shares held by Linse V. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 25,000 | $16.22 | $405,500.00 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 4 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,526,626 F4 · ownership.nature: Consists of securities held directly by Linse Capital CP IV, LLC ("Linse IV"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse IV. Mr. Linse has sole voting and investment power over the shares held by Linse IV. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 1,333 | $16.15 | $21,527.95 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 3 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,540,386 F3 · ownership.nature: Consists of securities held directly by Linse Capital CP III, LLC ("Linse III"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse III. Mr. Linse has the sole voting and investment power over the shares held by Linse III. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 14,333 | $16.15 | $231,477.95 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 2 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,812,908 F2 · ownership.nature: Consists of securities held directly by Linse Capital CP II, LLC ("Linse II"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse II. Mr. Linse has sole voting and investment power over the shares held by Linse II. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 1,333 | $16.14 | $21,514.62 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 1 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 20,075,404 F1 · ownership.nature: Consists of securities held directly by Linse Capital CP, LLC ("Linse I"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse I. Mr. Linse has sole voting and investment power over the shares held by Linse I. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 226,068 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 7 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 20,532 F13 · kind: On April 11, 2022, 226,068 shares of Common Stock held by Linse GP VI were distributed to the limited partners and general partners of Linse GP VI. F14 · ownership.nature: Consists of securities held by Linse GP VI. LCMPR is the general partner of Linse GP VI. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Linse GP VI. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 12, 2022 Filed Apr 15, 2022 21:05 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
SaleCommon Stock | 1,576,794 | $15.46 | $24,377,235.24 |
DisclosureSEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 7 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $16.09, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F8 · ownership.nature: Consists of securities held directly by Linse Capital LLC. Mr. Linse is the managing director of Linse Capital LLC. Mr. Linse has sole voting and investment power over the shares held by Linse Capital LLC. F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 1,314,768 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 6 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,639,558 F11 · kind: On April 11, 2022, 1,314,768 shares of Common Stock held by Linse Capital CP VI, LLC ("Linse VI") were distributed to the limited partners and general partners of Linse VI. F12 · ownership.nature: Consists of securities held directly by Linse VI. Linse Capital CP VI GP LP ("Linse GP VI") is the manager of Linse VI, and Linse Capital Management PR LLC ("LCMPR") is the general partner of Linse GP VI. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Linse VI. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 795,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 5 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,824,326 F9 · kind: On April 11, 2022, 795,885 shares of Common Stock held by Linse Capital CP V, LLC ("Linse V") were distributed to the limited partners and general partners of Linse V. F10 · ownership.nature: Consists of securities held directly by Linse V. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse V. Mr. Linse has sole voting and investment power over the shares held by Linse V. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 754,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 4 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,551,626 F7 · kind: On April 11, 2022, 754,032 shares of Common Stock held by Linse Capital CP IV, LLC ("Linse IV") were distributed to the limited partners and general partners of Linse IV. F8 · ownership.nature: Consists of securities held directly by Linse IV. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse IV. Mr. Linse has sole voting and investment power over the shares held by Linse IV. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 1,124,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 3 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,541,719 F5 · kind: On April 11, 2022, 1,124,268 shares of Common Stock of Linse Capital CP III, LLC ("Linse III") were distributed to the limited partners and general partners of Linse III. F6 · ownership.nature: Consists of securities held directly by Linse III. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse III. Mr. Linse has the sole voting and investment power over the shares held by Linse III. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 986,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 2 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,827,241 F3 · kind: On April 11, 2022, 986,069 shares of Common Stock held by Linse Capital CP II, LLC ("Linse II") were distributed to the limited partners and general partners of Linse II. F4 · ownership.nature: Consists of securities held directly by Linse II. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse II. Mr. Linse has sole voting and investment power over the shares held by Linse II. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:57 UTC |
Linse MichaelDirector · 10% owner
Linse Capital CP VI LLC10% owner
Linse Capital CP, LLC10% owner
Linse Capital CP II LLC10% owner
Linse Capital CP III, LLC10% owner
Linse Capital CP IV, LLC10% owner
Linse Capital CP V, LLC10% owner
Linse Capital LLC10% owner
|
OtherCommon Stock | 3,453,646 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 1 Linse Michael · CIK 0001838841 · Director · 10% owner Linse Capital CP VI LLC · CIK 0001821364 · 10% owner Linse Capital CP, LLC · CIK 0001672172 · 10% owner Linse Capital CP II LLC · CIK 0001687199 · 10% owner Linse Capital CP III, LLC · CIK 0001698115 · 10% owner Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner Linse Capital CP V, LLC · CIK 0001758721 · 10% owner Linse Capital LLC · CIK 0001849040 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 20,076,737 F1 · kind: On April 11, 2022, 3,453,646 shares of Common Stock held by Linse Capital CP, LLC ("Linse I") were distributed to the limited partners and general partners of Linse I. F2 · ownership.nature: Consists of securities held directly by Linse I. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse I. Mr. Linse has sole voting and investment power over the shares held by Linse I. F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 22:30 UTC |
WAGONER G RICHARD JRDirector
|
OtherCommon Stock | 3,895 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014731 · doc4.xml · nonDerivative · entry 1 WAGONER G RICHARD JR · CIK 0001181664 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 52,378 F1 · kind: Represents an acquisition of securities from an in-kind distribution, and not a purchase or sale, without additional consideration paid, and is therefore an exempt, non-matchable acquisition pursuant to Section 16(b). F2 · ownership.nature: The shares are held by the G. Richard Wagoner, Jr. Trust dated 7/13/1989, as amended and restated 10/19/2018 of which the Reporting Person is trustee. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:58 UTC |
Singh-Bushell EktaDirector
|
GrantCommon Stock | 17,131 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-014284 · doc4.xml · nonDerivative · entry 1 Singh-Bushell Ekta · CIK 0001707731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,131 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), each representing the right to receive one share of the issuer's common stock. The RSUs are subject to a service-based vesting requirement, which shall be satisfied in three annual installments on each anniversary of April 5, 2022, subject to the Reporting Person's continuous service with the issuer through each such anniversary. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:00 UTC |
Hughes Michael DSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $0.56 | Not disclosed |
DisclosureSEC source: 0000899243-22-013804 · doc4.xml · derivative · entry 3 Hughes Michael D · CIK 0001590392 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341,174 Underlying: Common Stock · 25,000 shares Expires 2028-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from August 16, 2018, subject to the Reporting Person's continuous service through each vesting date. F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from August 16, 2018, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:00 UTC |
Hughes Michael DSee Remarks
|
SaleCommon Stock | 25,000 | $19.73 | $493,180.00 |
DisclosureSEC source: 0000899243-22-013804 · doc4.xml · nonDerivative · entry 2 Hughes Michael D · CIK 0001590392 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,417 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.375 to $20.075. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:00 UTC |
Hughes Michael DSee Remarks
|
Exercise / conversionCommon Stock | 25,000 | $0.56 | $14,000.00 |
DisclosureSEC source: 0000899243-22-013804 · doc4.xml · nonDerivative · entry 1 Hughes Michael D · CIK 0001590392 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Jansen ColleenChief Marketing Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,500 | Not disclosed Strike: $0.44 | Not disclosed |
DisclosureSEC source: 0000899243-22-013805 · doc4.xml · derivative · entry 3 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,192 Underlying: Common Stock · 3,500 shares Expires 2026-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Jansen ColleenChief Marketing Officer
|
SaleCommon Stock | 3,500 | $19.88 | $69,580.00 |
DisclosureSEC source: 0000899243-22-013805 · doc4.xml · nonDerivative · entry 2 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,013 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Jansen ColleenChief Marketing Officer
|
Exercise / conversionCommon Stock | 3,500 | $0.44 | $1,540.00 |
DisclosureSEC source: 0000899243-22-013805 · doc4.xml · nonDerivative · entry 1 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Sidle EricSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $0.76 | Not disclosed |
DisclosureSEC source: 0000899243-22-013802 · doc4.xml · derivative · entry 3 Sidle Eric · CIK 0001837954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,979 Underlying: Common Stock · 30,000 shares Expires 2029-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from May 29, 2019, subject to the Reporting Person's continuous service through each vesting date. F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from May 29, 2019, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Sidle EricSee Remarks
|
SaleCommon Stock | 30,000 | $20.01 | $600,360.00 |
DisclosureSEC source: 0000899243-22-013802 · doc4.xml · nonDerivative · entry 2 Sidle Eric · CIK 0001837954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,497 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:00 UTC |
Sidle EricSee Remarks
|
Exercise / conversionCommon Stock | 30,000 | $0.76 | $22,800.00 |
DisclosureSEC source: 0000899243-22-013802 · doc4.xml · nonDerivative · entry 1 Sidle Eric · CIK 0001837954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 30, 2022 01:45 UTC |
Jansen ColleenChief Marketing Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0000899243-22-012735 · doc4.xml · derivative · entry 3 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,692 Underlying: Common Stock · 3,500 shares Expires 2026-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 30, 2022 01:45 UTC |
Jansen ColleenChief Marketing Officer
|
SaleCommon Stock | 3,500 | $19.00 | $66,500.00 |
DisclosureSEC source: 0000899243-22-012735 · doc4.xml · nonDerivative · entry 2 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,013 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 25, 2022 Filed Mar 30, 2022 01:45 UTC |
Jansen ColleenChief Marketing Officer
|
Exercise / conversionCommon Stock | 3,500 | $0.44 | $1,540.00 |
DisclosureSEC source: 0000899243-22-012735 · doc4.xml · nonDerivative · entry 1 Jansen Colleen · CIK 0001837912 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 17:01 UTC |
Gerdes HenrikChief Accounting Officer
|
SaleCommon Stock | 552 | $17.92 | $9,891.23 |
DisclosureSEC source: 0000899243-22-012106 · doc4.xml · nonDerivative · entry 1 Gerdes Henrik · CIK 0001688266 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,159 F1 · kind: The sale reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.77 to $17.92. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.